In order to remain compliant with the most current regulatory guidelines, we are updating the labeling on our SR formulations from Buprenorphine and Meloxicam SR to Buprenorphine and Meloxicam ER. The extended release formulations are designed to release the medications for up to 72 hours post a single subcutaneous injection.
Rest assured, there are no changes to the formulations, the only change is to the name on the label. The label change will take effect on July 1, 2022.
We know that any change, no matter how small, can be difficult. If you have any questions, please call our Customer Service Team at (866) 823-9314.
